Despite MRAS being the stronger binding partner for SHOC2–PP1C based on our biochemical analysis, we found no correlation between SHOC2 and MRAS dependency in the tumour cell lines, demonstrating that even in the cell lines that are highly SHOC2-dependent, MRAS is dispensable (Fig 3c,d). The gene discussed is MRAS; the disease is neoplasm.